NOVAVAX INC (NVAX)
US6700024010 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 96.40M | 122.30M | N/A | |||
| Cash Equivalents | 568.50M | 1.34B | 361.80M | 96.10M | 78.80M | |||
| Marketable Securities | N/A | N/A | 1.06B | 492.60M | 0.00 | |||
| Receivables | 297.24M | 82.40M | 455.00M | 262.00M | 7.50M | |||
| Inventories | 41.70M | 36.70M | N/A | N/A | N/A | |||
| Other Current Assets | 236.45M | 247.50M | 185.00M | 275.10M | 10.90M | |||
| Total Current Assets | 1.14B | 1.70B | 2.16B | 1.25B | 97.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 490.99M | 400.50M | 268.80M | 187.70M | 17.90M | |||
| Goodwill | 127.45M | 126.30M | 131.50M | 135.40M | 51.20M | |||
| Intangibles | N/A | N/A | 4.80M | 5.70M | 5.60M | |||
| Other Non-Current Assets | 35.16M | 28.50M | 16.60M | 5.40M | 1.10M | |||
| Total Non-Current Assets | 653.60M | 555.30M | 421.70M | 334.30M | 75.80M | |||
| TOTAL ASSETS | 1.80B | 2.26B | 2.58B | 1.58B | 173.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 5.14M | 352.10M | 130.50M | 105.90M | N/A | |||
| Accrued Expenses | 417.64M | 608.00M | 704.70M | 146.30M | 21.20M | |||
| Accounts Payable | 132.61M | 216.50M | 127.10M | 54.30M | 2.90M | |||
| Other Current Liabilities | 1.08B | 1.28B | 1.43B | 273.20M | 1.70M | |||
| Total Current Liabilities | 1.64B | 2.46B | 2.39B | 579.70M | 25.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 223.94M | 197.70M | 323.50M | 362.10M | 320.60M | |||
| Other Non-Current Liabilities | 655.34M | 235.10M | 214.60M | 13.50M | 12.60M | |||
| Total Non-Current Liabilities | 879.28M | 432.90M | 538.10M | 375.60M | 333.20M | |||
| TOTAL LIABILITIES | 2.51B | 2.89B | 2.93B | 955.30M | 359.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -4.82B | -4.28B | -3.62B | -1.87B | -1.43B | |||
| Additional Paid In Capital | 4.19B | 3.74B | 3.35B | 2.54B | 1.26B | |||
| Common Shares | 1.41M | 900.00K | 800.00K | 700.00K | 300.00K | |||
| Treasury Stock | -92.27M | -90.70M | -85.10M | -41.80M | -2.60M | |||
| Other Shareholders' Equity | 2.72M | -6.40M | -1.40M | 7.00M | -12.50M | |||
| Shares Outstanding | 139.51M | 86.00M | 75.80M | 71.00M | 32.40M | |||
| Tangible Book Value per Share | -6.05 | -8.84 | -6.44 | 6.85 | -7.49 | |||
| Total Shareholders' Equity | -716.93M | -634.10M | -351.70M | 627.20M | -186.00M | |||
| TOTAL LIABILITIES AND EQUITY | 1.80B | 2.26B | 2.58B | 1.58B | 173.00M | |||
| Statistics | ||||||||
| Debt/Equity | -0.31 | -0.31 | -0.92 | 0.58 | -1.72 | |||
| Current Ratio | 0.70 | 0.69 | 0.90 | 2.15 | 3.77 | |||
| Return On Assets (ROA) | -30.32% | -29.13% | -67.67% | -26.43% | -76.71% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -66.69% | N/A | |||
All data in USD